EXENDIN AND EXENDIN AGONISTS FOR EATING DISORDERS
    7.
    发明申请
    EXENDIN AND EXENDIN AGONISTS FOR EATING DISORDERS 审中-公开
    排除和排除疾病引发激素

    公开(公告)号:US20130023470A1

    公开(公告)日:2013-01-24

    申请号:US13618922

    申请日:2012-09-14

    IPC分类号: A61K38/26 A61P3/00 A61P9/00

    摘要: Methods for treating conditions or disorders which can be alleviated by reducing food intake are disclosed which comprise administration of an effective amount of an exendin or an exendin agonist, alone or in conjunction with other compounds or compositions that affect satiety. The methods are useful for treating conditions or disorders, including obesity, Type II diabetes, eating disorders, and insulin-resistance syndrome. The methods are also useful for lowering the plasma glucose level, lowering the plasma lipid level, reducing the cardiac risk, reducing the appetite, and reducing the weight of subjects. Pharmaceutical compositions for use in the methods of the invention are also disclosed.

    摘要翻译: 公开了通过减少食物摄入可以缓解的病症或病症的方法,其包括单独施用有效量的毒蜥外泌肽或毒蜥外泌肽激素,或与影响饱腹感的其它化合物或组合物联合施用。 该方法可用于治疗条件或障碍,包括肥胖,II型糖尿病,进食障碍和胰岛素抵抗综合征。 该方法对于降低血浆葡萄糖水平,降低血浆脂质水平,降低心脏风险,降低食欲和降低受试者的体重也是有用的。 还公开了用于本发明方法的药物组合物。

    Treatment of pancreatitis with amylin
    9.
    发明授权
    Treatment of pancreatitis with amylin 失效
    用胰岛淀粉样多巴胺治疗胰腺炎

    公开(公告)号:US08168233B2

    公开(公告)日:2012-05-01

    申请号:US10671304

    申请日:2003-09-24

    IPC分类号: A61K36/00

    CPC分类号: A61K38/22

    摘要: The disclosed invention provides for the treatment of pancreatitis, and the alleviation of pain associated therewith, with amylin, amylin agonists and amylin analogs.

    摘要翻译: 所公开的发明提供胰岛淀粉样多肽,胰岛淀粉样多肽激动剂和胰岛淀粉样多肽类似物治疗胰腺炎以及与之相关的疼痛的缓解。

    EXENDINS AND EXENDIN AGONIST ANALOGS TO REGULATE GASTROINTESTINAL MOTILITY
    10.
    发明申请
    EXENDINS AND EXENDIN AGONIST ANALOGS TO REGULATE GASTROINTESTINAL MOTILITY 审中-公开
    排除和排除激素类似物调节气体动力学

    公开(公告)号:US20120004168A1

    公开(公告)日:2012-01-05

    申请号:US13226975

    申请日:2011-09-07

    摘要: Methods for reducing gastric motility and delaying gastric emptying for therapeutic and diagnostic purposes are disclosed which comprise administration of an effective amount of an exendin or an exendin agonist. Methods for treating conditions associated with elevated, inappropriate, or undesired post-prandial blood glucose levels are disclosed which comprise administration of an effective amount of an exendin or an exendin agonist alone or in conjunction with other anti-gastric emptying agents.

    摘要翻译: 公开了减少胃动力和延迟胃排空用于治疗和诊断目的的方法,其包括施用有效量的毒蜥外泌肽或毒蜥外泌肽激动剂。 公开了治疗与升高的,不适当的或不期望的餐后血糖水平相关的病症的方法,其包括单独施用有效量的毒蜥外泌肽或毒蜥外泌肽激素,或与其他抗胃排空剂联合施用。